Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Gepant treAtments: EffectIveNess and tolERability (GAINER) — Stella

Home/Migraine/Gepant treAtments: EffectIveNess and tolERability (GAINER)

View on ClinicalTrials.gov

Recruiting

Back to Migraine trials

Gepant treAtments: EffectIveNess and tolERability (GAINER)

Trial locations(2 sites)

Italy

SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi, Florence

IRCCS National Neurological Institute "C. Mondino" Foundation, Pavia

Key details

Sponsor

University of Florence

Collaborators

IRCCS National Neurological Institute "C. Mondino" Foundation, Società Italiana per lo Studio delle Cefalee

Enrollment target

~100 participants

Started

June 2023

Primary completion

June 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.